| htlv-i and -ii in intravenous drug users from sweden and denmark. | 693 ivdu (intravenous drug user) sera from copenhagen, malmö and stockholm were tested, 247 retro- and 446 prospectively, for antibodies to human t-lymphotropic virus (htlv), types i and ii, by means of a commercial whole-virus eia and/or an htlv-i/-ii peptide-based eia. positive eia reactions were checked and typed by electrophoretic immunoblotting, a differential peptide-based eia and nucleic acid amplification/hybridization with htlv-i and -ii specific primers and probes. 3 (0.7%) of the pros ... | 1994 | 8191236 |